英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
chaufen查看　chaufen　在百度字典中的解释百度英翻中〔查看〕
chaufen查看　chaufen　在Google字典中的解释Google英翻中〔查看〕
chaufen查看　chaufen　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Advanced and metastatic prostate cancer: ESMO Clinical . . .
    This ESMO Clinical Practice Guideline (CPG) focuses on advanced and metastatic prostate cancer This includes metastatic castration-sensitive prostate cancer (mCSPC), non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC)
  • Advanced and metastatic prostate cancer: ESMO Clinical . . .
    This includes metastatic castration-sensitive prostate cancer (mCSPC), non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC) The management of early-stage disease is covered in the ESMO CPG for local and locoregional prostate cancer 1
  • Real-world treatment patterns and outcomes in advanced . . .
    Time burden and healthcare costs associated with docetaxel in patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating an androgen receptor pathway inhibitor (ARPI) –based regimen This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium This
  • Niraparib and abiraterone acetate plus prednisone for HRR . . .
    We hypothesized that PARP inhibition within 6 months of starting androgen deprivation therapy for metastatic castration-sensitive prostate cancer (mCSPC) could be effective and improve
  • Combination Therapies in Locally Advanced and Metastatic . . .
    The treatment landscape for prostate cancer has evolved significantly over the past decade, with a focus now on early treatment intensification This review summarises the key data evaluating combination therapy in locally advanced as well as metastatic hormone-sensitive prostate cancer It aims to synthesise and provide the most up-to-date contemporary evidence to provide a concise resource
  • Prognostic Value of Bone Metastases by Extent of Disease and . . .
    Backgrounds: High-volume (HV) metastatic castration-sensitive prostate cancer (mCSPC) is an aggressive disease Despite this, we aimed to assess the metastatic patterns associated with a favorable prognosis in HV disease with bone metastasis (BM), including BM’s coexistence with lung metastasis (LM) Methods: We retrospectively analyzed 379 patients with synchronous mCSPC They were
  • Three new drugs for metastatic prostate cancer approved by FDA
    FDA approves new options that may allow some men with advanced prostate cancer to delay or avoid chemotherapy These provide more choices for people with metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC)
  • The Rapidly Evolving Treatment Landscape of Metastatic . . .
    Abstract The management of metastatic hormone-sensitive prostate cancer (mHSPC) or castration-sensitive prostate cancer (mCSPC) has become increasingly complex with the tremendous progress that has been made in this space within the past few decades
  • Real-world comparative outcomes of abiraterone vs . . .
    Real-world comparative outcomes of abiraterone vs enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC): A propensity-matched analysis from the TriNetX Global Health Research Network If you have the appropriate software installed, you can download article citation data to the citation manager of your choice
  • Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    The initial treatment for metastatic prostate cancer is androgen-deprivation therapy (ADT) through medical or surgical castration





中文字典-英文字典  2005-2009